INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 281 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,096 | +95.9% | 59,439 | +138.2% | 0.04% | +191.7% |
| Q2 2023 | $1,580 | -63.0% | 24,954 | -68.4% | 0.01% | -76.0% |
| Q1 2023 | $4,272 | +231.2% | 78,890 | +223.7% | 0.05% | +212.5% |
| Q4 2022 | $1,290 | -99.9% | 24,369 | +9.5% | 0.02% | +23.1% |
| Q3 2022 | $1,035,000 | +27.1% | 22,249 | +56.0% | 0.01% | +44.4% |
| Q2 2022 | $814,000 | +337.6% | 14,262 | +370.2% | 0.01% | +800.0% |
| Q1 2022 | $186,000 | -94.1% | 3,033 | -95.0% | 0.00% | -94.1% |
| Q4 2021 | $3,153,000 | +293.6% | 60,248 | +180.4% | 0.02% | +325.0% |
| Q3 2021 | $801,000 | -3.8% | 21,483 | +5.2% | 0.00% | 0.0% |
| Q2 2021 | $833,000 | +64.3% | 20,418 | +36.8% | 0.00% | +33.3% |
| Q1 2021 | $507,000 | -87.6% | 14,930 | -88.4% | 0.00% | -86.4% |
| Q4 2020 | $4,095,000 | +94.2% | 128,780 | +56.7% | 0.02% | +69.2% |
| Q3 2020 | $2,109,000 | +163.6% | 82,190 | +163.9% | 0.01% | +85.7% |
| Q2 2020 | $800,000 | +145.4% | 31,150 | +47.0% | 0.01% | +133.3% |
| Q1 2020 | $326,000 | -11.9% | 21,194 | +96.8% | 0.00% | 0.0% |
| Q4 2019 | $370,000 | +270.0% | 10,771 | +30.8% | 0.00% | +200.0% |
| Q1 2019 | $100,000 | -58.2% | 8,235 | -60.8% | 0.00% | -50.0% |
| Q4 2018 | $239,000 | -75.2% | 21,024 | -52.7% | 0.00% | -71.4% |
| Q3 2018 | $965,000 | +407.9% | 44,454 | +268.6% | 0.01% | +250.0% |
| Q3 2017 | $190,000 | +84.5% | 12,060 | +45.9% | 0.00% | +100.0% |
| Q2 2017 | $103,000 | -63.3% | 8,266 | -55.6% | 0.00% | -50.0% |
| Q4 2016 | $281,000 | +142.2% | 18,608 | +344.3% | 0.00% | +100.0% |
| Q1 2016 | $116,000 | -2.5% | 4,188 | +40.7% | 0.00% | 0.0% |
| Q3 2015 | $119,000 | -60.3% | 2,977 | -83.3% | 0.00% | -50.0% |
| Q2 2014 | $300,000 | – | 17,816 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $42,833,000 | 8.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 308,819 | $18,897,000 | 7.82% |
| Vahanian & Associates Financial Planning Inc. | 45,533 | $2,786,000 | 6.44% |
| DCF Advisers, LLC | 238,500 | $14,594,000 | 6.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 50,956 | $20,930,000 | 4.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,531,923 | $93,738,000 | 2.86% |
| Nicholas Investment Partners, LP | 562,373 | $34,412,000 | 2.45% |
| Bellevue Group AG | 3,429,619 | $209,859,000 | 2.44% |
| WASATCH ADVISORS LP | 7,477,868 | $457,571,000 | 2.25% |
| Quantum Private Wealth, LLC | 73,772 | $4,514,000 | 1.95% |